首页> 外文期刊>Leukemia Research Reports >A primary esophageal MALT lymphoma patient with Helicobacter pylori infection achieved complete remission after H. pylori eradication without anti-lymphoma treatment
【24h】

A primary esophageal MALT lymphoma patient with Helicobacter pylori infection achieved complete remission after H. pylori eradication without anti-lymphoma treatment

机译:原发性食管MALT淋巴瘤患者幽门螺杆菌感染后, H完全缓解。未经抗淋巴瘤治疗的幽门螺旋杆菌根除术

获取原文
       

摘要

Primary esophageal lymphoma is an extremely rare disease. We report a 76-year-old woman with esophageal lymphoma who achieved remission after Helicobacter pylori (HP) eradication. Esophagogastroduodenoscopy (EGD) revealed a mass in the lower esophagus, and she was diagnosed with stage IE mucosa-associated lymphoid tissue (MALT) lymphoma. She rejected any anti-lymphoma treatment except for HP eradication. Follow-up EGD demonstrated the disappearance of the esophageal MALT lymphoma 2 months after HP eradication, and she remained in remission for more than 3 years. Our results demonstrate that HP eradication may be effective as initial therapy in primary esophageal MALT lymphoma patients with HP infection.
机译:原发性食管淋巴瘤是一种极为罕见的疾病。我们报告了一名76岁的食管淋巴瘤妇女,在幽门螺杆菌(HP)根除后获得缓解。食管胃十二指肠镜检查(EGD)显示食管下段有肿块,并被诊断为IE期粘膜相关淋巴样组织(MALT)淋巴瘤。她拒绝除根除HP以外的任何抗淋巴瘤治疗方法。随访EGD证实,根除HP后2个月,食管MALT淋巴瘤消失,并且她的缓解期超过3年。我们的结果表明,根除HP可能有效地作为HP感染的原发性食管MALT淋巴瘤患者的初始治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号